Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02575911 · ClinicalTrials.gov registry record · NA
Accuracy of LASIK Flaps Created With the LenSx® Femtosecond Laser - A Pilot Study
A NA study, sponsored by Alcon Research.
- Completed
- Registry status
- NA
- Development phase
- 34
- Enrollment target
NCT02575911: Completed NA study, sponsored by Alcon Research.
NCT02575911 is a NA study that has completed, run by Alcon Research. The registered enrollment target is 34 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02575911, a NA study, has completed, sponsored by Alcon Research.
- COMPLETED
- Registry status
- NA
- Development phase
- 34 participants
- Enrollment target
Study Summary
The purpose of this study is to evaluate the thickness accuracy of Laser-assisted in situ keratomileusis (LASIK) flaps created with the LenSx® Laser.
Primary Outcome
Flap thickness was assessed by optical coherence tomography (OCT) and averaged from 3 separate scans. Flap thickness accuracy was defined as the mean difference between the achieved and desired (desired subtracted from achieved) flap thickness. A positive number represents a postoperative flap thickness that is thicker than the expected flap thickness and vice versa for a negative number. Each eye contributed separately to the analysis.
Interventions
- DEVICE Femtosecond Laser System
- PROCEDURE LASIK surgery
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 34 participants |
| Start Date | 2015-10-28 |
| Est. Completion | 2016-04-09 |
| Phase | NA |
What the finished NCT02575911 record still lists
NCT02575911 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 34 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower).
The record links to 0 conditions, and to 2 interventions - of which Femtosecond Laser System is the first listed.
NCT02575911 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02575911 about?
NCT02575911 is a clinical study titled "Accuracy of LASIK Flaps Created With the LenSx® Femtosecond Laser - A Pilot Study". The purpose of this study is to evaluate the thickness accuracy of Laser-assisted in situ keratomileusis (LASIK) flaps created with the LenSx® Laser.
What is the current status of trial NCT02575911?
This trial is currently completed. It is a NA study. The enrollment target is 34 participants. The study started on 2015-10-28. Estimated completion is 2016-04-09.
What interventions are being tested in trial NCT02575911?
The interventions under investigation include: Femtosecond Laser System (DEVICE), LASIK surgery (PROCEDURE).
Who is sponsoring clinical trial NCT02575911?
This trial is sponsored by Alcon Research, which has 275 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT02575911's enrollment target sits among peer trials
34 1570th of 2000 higher than 427 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02897063 · 34 participants · Phase 1
Effects of Midodrine and Droxidopa on Splanchnic Capacitance in Autonomic Failure
- NCT03906617 · 34 participants · Phase 4
Bupivacaine/Epinephrine +Dexamethasone vs. Liposomal Bupivacaine
- NCT03992378 · 34 participants · NA
Neuromodulation to Regulate Inflammation and Autonomic Imbalance in Sepsis
- NCT04047849 · 34 participants · Phase 4
Latency Antibiotics in Previable PPROM, 18 0/7- 22 6/7 WGA
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI